Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Wahana Inti Makmur Tbk. (NASI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Wahana Inti Makmur Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Wahana Inti Makmur Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Wahana Inti Makmur Tbk. trades at Rp165 (market cap 131.61B, 4.22M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Wahana Inti Makmur Tbk. is more actively traded (4.22M versus 324K). Which is the better fit depends on your goals.

NASIOBAT
Market Cap
131.61B166.01B
Volume
4.22M324K
Lot
42.25K3.24K
Turnover
683.98M77.68M
Average Price
161.9239.75
Value
683.98M77.68M
Indicative Equilibrium Price
165240
Indicative Equilibrium Volume
1.61K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NASI
View details
OBAT
View details

About Wahana Inti Makmur Tbk.

PT Wahana Inti Makmur Tbk (the Company) is established based on Deed of Establishment No. 02 dated February 14, 2015 made by Dr. Tio Jeffrens Maranella, S.H., Notary in Jakarta. The Company started its commercial operations in February 2015.

Read more on NASI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT